20845-38-9 Usage
Uses
Used in Pharmaceutical Industry:
2-(1-Methylpiperidin-4-yl)ethanamine is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs, particularly those targeting specific biological pathways or receptors.
Used in Chemical Synthesis:
In the field of chemical synthesis, 2-(1-Methylpiperidin-4-yl)ethanamine serves as a versatile building block for creating a wide range of organic compounds. Its ability to form stable bonds with other molecules makes it a valuable asset in the synthesis of complex organic structures.
Used in Research and Development:
2-(1-Methylpiperidin-4-yl)ethanamine is utilized in research and development settings to explore its potential applications and properties. Scientists and researchers use 2-(1-Methylpiperidin-4-yl)ethanamine to investigate its reactivity, stability, and interactions with other chemicals, which can lead to the discovery of new compounds and applications.
Used in Material Science:
In material science, 2-(1-Methylpiperidin-4-yl)ethanamine may be employed as a component in the development of new materials with specific properties. Its unique structure and reactivity can contribute to the creation of materials with improved performance characteristics, such as enhanced stability, durability, or specific functional properties.
Check Digit Verification of cas no
The CAS Registry Mumber 20845-38-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,8,4 and 5 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 20845-38:
(7*2)+(6*0)+(5*8)+(4*4)+(3*5)+(2*3)+(1*8)=99
99 % 10 = 9
So 20845-38-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H18N2/c1-10-6-3-8(2-5-9)4-7-10/h8H,2-7,9H2,1H3
20845-38-9Relevant academic research and scientific papers
SULFONYLBENZODIAZEPINONE ACETAMIDES AS BRADYKININ ANTAGONISTS
-
Page 58, (2010/02/06)
Disclosed are compounds, of formula (I) which are bradykinin antagonists and are useful to treat diseases or relieve adverse symptoms associated with disease conditions in mammals mediated by bradykinin. Certain of the compounds exhibit increased potency and are expected to also exhibit an increased duration of action.
Indazole derivatives having monocyclic amine
-
, (2008/06/13)
An indazole compound having the formula (I): wherein: R1 is hydrogen, C1 -C6 alkyl, C3 -C6 alkenyl or C3 -C6 cycloalkyl; Q is carbonyl, thiocarbonyl or methylene; and R2 is a group of the formula (II) or (IV); STR1 wherein R1 is C1 -C6 alkyl, C3 -C6 alkenyl or benzyl, of which a phenyl group thereof is optionally mono- or di-substituted by the same or different halogen or methoxy; m is 0 to 2; n and o is 1 or 2. The compound exhibits 5-HT4 receptor agonist activity.
